According to Ocuphire Pharma's latest financial reports the company has $50.51 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $50.51 M | 18.35% |
2022-12-31 | $42.68 M | 72.44% |
2021-12-31 | $24.75 M | 50.94% |
2020-12-31 | $16.39 M | 966.95% |
2019-12-31 | $1.53 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $95.88 M | 89.80% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $20.82 M | -58.78% | ๐บ๐ธ USA |